DS Healthcare Group Inc  

(Public, NASDAQ:DSKX)   Watch this stock  
0.000 (0.00%)
Real-time:   10:31AM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week     -
Open     -
Vol / Avg. 0.00/62,115.00
Mkt cap 11.96M
P/E     -
Div/yield     -
EPS -0.02
Shares 22.56M
Beta     -
Inst. own 17%

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin -15.71% -9.78%
Operating margin -14.80% -9.44%
EBITD margin - -8.74%
Return on average assets -23.46% -14.33%
Return on average equity -35.23% -24.09%
Employees 46 -
CDP Score - -


1601 Green Rd
POMPANO BEACH, FL 33064-1076
United States - Map
+1-888-4047770 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


DS Healthcare Group, Inc. (DS Healthcare), doing business as DS Laboratories, is a personal-care, product development and marketing company. The Company offers the following lines of products: hair care, skin care, personal care and OTC Drugs. The Company is a provider of Liposome Technology, which acts as a carrier agent, and Nanosome Technology, which acts as a delivery vehicle and infuses active compounds into focused cells of its products. The Company formulates, markets and sells products through specialty retailers, spas, salons, pharmacies and other distributors. The Company's principal thinning hair products include Revita, Revita LT and Spectral; Hair Care products consist of Dandrene, Nia and Radia; Skin Care products comprises Hydroviton.CR, Keramene, Oligio.DX and Trioxil, and Personal Care products include Nirena and Spectral.Lash, all of which are marketed under the DS Laboratories brand.

Officers and directors

Manuel Gonzalez Chief Commercial Officer
Bio & Compensation  - Reuters